Join
Live feed
·
INSIDERFilingvia Quantisnow
Turn Therapeutics Inc. logo

Officer Chaudhary Zuraiz bought $8,750 worth of shares (2,500 units at $3.50), increasing direct ownership by 25% to 12,500 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TTRX· Turn Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TTRX (Turn Therapeutics Inc.) and more on Quantisnow.